Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP2 | P08253 | 5/20 | 0.46 |
| ▸ | MMP9 | P14780 | 5/20 | 0.46 |
| ▸ | MMP8 | P22894 | 4/20 | 0.46 |
| ▸ | MMP13 | P45452 | 4/20 | 0.46 |
| ▸ | CPT1A | P50416 | 1/20 | 0.43 |
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
| ▸ | THRB | P10828 | 1/20 | 0.42 |
| ▸ | MMP3 | P08254 | 1/20 | 0.39 |
| ▸ | SIRT2 | Q8IXJ6 | 1/20 | 0.37 |
| ▸ | MGLL | Q99685 | 2/20 | 0.37 |
| ▸ | PTGS1 | P23219 | 2/20 | 0.37 |
| ▸ | PTGS2 | P35354 | 2/20 | 0.37 |
| ▸ | FAAH | O00519 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3684753 | 1.00 | MMP2 (0.46) | MMP2MMP9MMP8MMP13CPT1A | |
| SCHEMBL468545 | 0.77 | MMP9 (0.67) | MMP2MMP9MMP8MMP13MMP3 | |
| SCHEMBL5450754 | 0.77 | MMP9 (0.67) | MMP2MMP9MMP8MMP13MMP3 | |
| SCHEMBL21958419 | 0.77 | MMP2 (0.41) | MMP2MMP9MMP8MMP13CPT1A | |
| Hexadecane SCHEMBL23499901 | 0.65 | TSHR (1.00) | TSHRTHRB | |
| Tetradecane SCHEMBL25387874 | 0.65 | TSHR (1.00) | TSHRTHRB | |
| Dodecane SCHEMBL3169410 | 0.65 | TSHR (1.00) | TSHRTHRB | |
| Tetradecane SCHEMBL23924271 | 0.65 | TSHR (1.00) | TSHRTHRB | |
| Undecane SCHEMBL20767628 | 0.65 | TSHR (1.00) | TSHRTHRB | |
| Decane SCHEMBL3666565 | 0.65 | TSHR (1.00) | TSHRTHRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 36 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250109245-A1 | PREPARATION OF UNSATURATED POLYESTERS | EASTMAN CHEMICAL COMPANY (US) | 2025-04-03 | — | — | US | disclosed |
| EP-4473036-A1 | PREPARATION OF UNSATURATED POLYESTERS | Eastman Chemical Company (US) | 2024-12-11 | — | — | EP | disclosed |
| WO-2023147330-A1 | PREPARATION OF UNSATURATED POLYESTERS | EASTMAN CHEMICAL COMPANY (US) | 2023-08-03 | — | — | WO | disclosed |
| EP-3353228-B1 | POLYMERS CONTAINING CYCLOBUTANEDIOL AND 2,2-BIS(HYDROXYMETHYL)ALKYLCARBOXYLIC ACID | EASTMAN CHEM CO (US) | 2022-09-14 | — | — | EP | disclosed |
| EP-2912095-B1 | COPOLYESTERS CONTAINING NEOPENTYL GLYCOL AND 2,2,4,4-TETRAALKYL-1,3-CYCLOBUTANEDIOL | EASTMAN CHEM CO (US) | 2018-11-14 | — | — | EP | disclosed |
| EP-3353228-A1 | POLYMERS CONTAINING CYCLOBUTANEDIOL AND 2,2-BIS(HYDROXYMETHYL)ALKYLCARBOXYLIC ACID | Eastman Chemical Company (US) | 2018-08-01 | — | — | EP | disclosed |
| US-20180002482-A1 | POLYMERS CONTAINING CYCLOBUTANEDIOL AND 2,2-BIS(HYDROXYMETHYL)ALKYLCARBOXYLIC ACID | EASTMAN CHEMICAL COMPANY (US) | 2018-01-04 | — | — | US | disclosed |
| WO-2017053379-A1 | POLYMERS CONTAINING CYCLOBUTANEDIOL AND 2,2-BIS(HYDROXYMETHYL)ALKYLCARBOXYLIC ACID | EASTMAN CHEMICAL COMPANY (US) | 2017-03-30 | — | — | WO | disclosed |
| US-20170088665-A1 | POLYMERS CONTAINING CYCLOBUTANEDIOL AND 2,2 BIS(HYDROXYMETHYL) AlKYLCARBOXYLIC ACID | EASTMAN CHEMICAL COMPANY (US) | 2017-03-30 | — | — | US | disclosed |
| EP-2734566-B1 | SULFOPOLYESTER POLYMER COMPOSITIONS WITH IMPROVED WATER DISPERSIBILITY | EASTMAN CHEM CO (US) | 2016-11-02 | — | — | EP | disclosed |
| US-7838707-B2 | for a specific cis:trans isomer ratio in order to control glass transition temperatures and/or crystallization rates in copolyesters; hydrogenation of a 2,2,4,4-tetraalkylcyclobutane-1,3-dione from the pyrolysis of isobutyric anhydride and dimerization of the resulting dimethylketene | EASTMAN CHEMICAL COMPANY (US) | 2010-11-23 | — | — | US | disclosed |
| US-7582804-B2 | by hydrogenation of a 2,2,4,4-tetraalkylcyclobutane-1,3-dione; cesium and cobalt promoters; specific cis/trans isomer ratio in order to control glass transition temperatures and/or crystallization rates in copolyesters | EASTMAN CHEMICAL COMPANY (US) | 2009-09-01 | — | — | US | disclosed |
| US-7560600-B2 | by hydrogenation of a 2,2,4,4-tetraalkylcyclobutane-1,3-dione in the presence of an zirconium-promoted nickel-based catalyst; specific cis/trans isomer ratio in order to control glass transition temperatures and/or crystallization rates in copolyesters | EASTMAN CHEMICAL COMPANY (US) | 2009-07-14 | — | — | US | disclosed |
| US-7524994-B2 | by hydrogenation of a 2,2,4,4-tetraalkylcyclobutane-1,3-dione; specific cis/trans isomer ratio in order to control glass transition temperatures and/or crystallization rates in copolyesters | EASTMAN CHEMICAL COMPANY (US) | 2009-04-28 | — | — | US | disclosed |
| US-7521583-B2 | Process for the preparation of tetraalkylcyclobutane-1,3-diol in the presence of a cobalt-based catalyst | EASTMAN CHEMICAL COMPANY (US) | 2009-04-21 | — | — | US | disclosed |
| US-20080154069-A1 | for a specific cis:trans isomer ratio in order to control glass transition temperatures and/or crystallization rates in copolyesters; hydrogenation of a 2,2,4,4-tetraalkylcyclobutane-1,3-dione from the pyrolysis of isobutyric anhydride and dimerization of the resulting dimethylketene | EASTMAN CHEMICAL COMPANY (US) | 2008-06-26 | — | — | US | disclosed |
| US-20080132742-A1 | by hydrogenation of a 2,2,4,4-tetraalkylcyclobutane-1,3-dione; cesium and cobalt promoters; specific cis/trans isomer ratio in order to control glass transition temperatures and/or crystallization rates in copolyesters | EASTMAN CHEMICAL COMPANY (US) | 2008-06-05 | — | — | US | disclosed |
| US-20080132737-A1 | by hydrogenation of a 2,2,4,4-tetraalkylcyclobutane-1,3-dione; specific cis/trans isomer ratio in order to control glass transition temperatures and/or crystallization rates in copolyesters | EASTMAN CHEMICAL COMPANY (US) | 2008-06-05 | — | — | US | disclosed |
| US-20080132738-A1 | by hydrogenation of a 2,2,4,4-tetraalkylcyclobutane-1,3-dione in the presence of an zirconium-promoted nickel-based catalyst; specific cis/trans isomer ratio in order to control glass transition temperatures and/or crystallization rates in copolyesters | EASTMAN CHEMICAL COMPANY (US) | 2008-06-05 | — | — | US | disclosed |
| US-20080132739-A1 | PROCESS FOR THE PREPARATION OF TETRAALKYLCYCLOBUTANE-1,3-DIOL IN THE PRESENCE OF A COBALT-BASED CATALYST | EASTMAN CHEMICAL COMPANY (US) | 2008-06-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080132739-A1 | PROCESS FOR THE PREPARATION OF TETRAALKYLCYCLOBUTANE-1,3-DIOL IN THE PRESENCE OF A COBALT-BASED CATALYST | TET1, TET3, HPD | MMP2 4340/4885MMP9 3783/4885MMP8 3602/4885 |
| US-20080132738-A1 | by hydrogenation of a 2,2,4,4-tetraalkylcyclobutane-1,3-dione in the presence of an zirconium-promoted nickel-based catalyst; specific cis/trans isomer ratio in order to control glass transition temperatures and/or crystallization rates in copolyesters | ZRANB2, RCC1, TELO2 | MMP2 3910/4885MMP9 3976/4885MMP8 1915/4885 |
| US-20080132742-A1 | by hydrogenation of a 2,2,4,4-tetraalkylcyclobutane-1,3-dione; cesium and cobalt promoters; specific cis/trans isomer ratio in order to control glass transition temperatures and/or crystallization rates in copolyesters | CA3, TELO2, CA1 | MMP2 3054/4885MMP9 3602/4885MMP8 2960/4885 |
| US-20080154069-A1 | for a specific cis:trans isomer ratio in order to control glass transition temperatures and/or crystallization rates in copolyesters; hydrogenation of a 2,2,4,4-tetraalkylcyclobutane-1,3-dione from the pyrolysis of isobutyric anhydride and dimerization of the resulting dimethylketene | CA3, CA1, CA2 | MMP2 4299/4885MMP9 4630/4885MMP8 4010/4885 |
| US-20080132737-A1 | by hydrogenation of a 2,2,4,4-tetraalkylcyclobutane-1,3-dione; specific cis/trans isomer ratio in order to control glass transition temperatures and/or crystallization rates in copolyesters | TELO2, CA3, CA1 | MMP2 4082/4885MMP9 4413/4885MMP8 3190/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.